CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Variation in treatment of acute childhood wheeze in emergency departments of the United Kingdom and Ireland: An international survey of clinician practice
Authors
J. Barling
J. Bayreuther
+34 more
C. Bevan
T. Bolger
D. Burke
V. Choudhery
J. Criddle
E. Dalzell
F. Davies
C. Dieppe
I. Doull
J. Grice
G. Hadley
S. Hartshorn
S. Hartshorn
A. Kidd
M. D. Lyttle
I. Maconochie
R. McNamara
M. Mitchelson
I. Morris
N. Mullen
J. Mulligan
R. O'Sullivan
R. O'Sullivan
A. Parikh
K. Potier
S. Potter
Colin Victor Eric Powell
Z. Roberts
G. Robinson
J. Ross
A. Rowland
J. Smith
S. Wong
P. Younge
Publication date
20 January 2015
Publisher
'BMJ'
Doi
Cite
Abstract
© 2015, BMJ Publishing Group. All rights reserved. Objective: National clinical guidelines for childhood wheeze exist, yet despite being one of the most common reasons for childhood emergency department (ED) attendance, signi ficant variation in practice occurs in other settings. We, therefore, evaluated practice variations of ED clinicians in the UK and Ireland. Design: Two-stage survey undertaken in March 2013. Stage one examined department practice and stage two assessed ED consultant practice in acute childhood wheeze. Questions interrogated pharmacological and other management strategies, including inhaled and intravenous therapies. Setting and participants: Member departments of Paediatric Emergency Research in the United Kingdom and Ireland and ED consultants treating children with acute wheeze. Results: 30 EDs and 183 (81%) clinicians responded. 29 (97%) EDs had wheeze guidelines and 12 (40%) had care pathways. Variation existed between clinicians in dose, timing and frequency of inhaled bronchodilators across severities. When escalating to intravenous bronchodilators, 99 (54%) preferred salbutamol first line, 52 (28%) magnesium sulfate (MgSO4) and 27 (15%) aminophylline. 87 (48%) administered intravenous bronchodilators sequentially and 30 (16%) concurrently, with others basing approach on case severity. 146 (80%) continued inhaled therapy after commencing intravenous bronchodilators. Of 170 who used intravenous salbutamol, 146 (86%) gave rapid boluses, 21 (12%) a longer loading dose and 164 (97%) an ongoing infusion, each with a range of doses and durations. Of 173 who used intravenous MgSO4, all used a bolus only. 41 (24%) used non-invasive ventilation. Conclusions: Signi ficant variation in ED consultant management of childhood wheeze exists despite the presence of national guidance. This reflects the lack of evidence in key areas of childhood wheeze and emphasises the need for further robust multicentre research studies
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
UWE Bristol Research Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:uwe-repository.worktribe.c...
Last time updated on 08/06/2020
Supporting member
Online Research @ Cardiff
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:https://orca.cardiff.ac.uk...
Last time updated on 15/07/2021